$GATO
Gatos Silver, Inc. Stock $gato

$gato Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024020650 Filed on May 06, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$7.919M	$6.998M
YoY Change	28.56%	24.96%
Operating Profit
YoY Change
Interest Expense		$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$17.20M	$9.573M
YoY Change	1472.58%	572.73%
Pretax Income	$9.285M	$2.575M
YoY Change	-358.42%	206.55%
Income Tax	$129.0K	$43.00K
% Of Pretax Income	1.39%	1.67%
Net Earnings	$9.156M	$2.532M
YoY Change	-354.83%	203.23%
Net Earnings / Revenue
Basic Earnings Per Share	$0.13	$0.04
Diluted Earnings Per Share	$0.13	$0.04
COMMON SHARES
Basic Shares Outstanding	69.18M shares	69.18M shares	69.16M shares
Diluted Shares Outstanding	71.10M shares	70.42M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$82.48M	$70.59M	$55.48M
Short-Term Investments
Other Short-Term Assets	$1.593M	$2.486M	$22.64M
YoY Change	-89.84%	-84.81%	34.21%
Inventory
Prepaid Expenses	$924.0K	$1.379M	$1.914M
Receivables
Other Receivables
Total Short-Term Assets	$84.22M	$73.54M	$78.69M
YoY Change	212.18%	145.64%	120.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$305.2M	$308.2M	$321.9M
YoY Change	-13.85%	-12.64%	-7.44%
Other Assets	$382.0K	$415.0K	$38.00K
YoY Change	768.18%	730.0%	-36.67%
Total Long-Term Assets	$305.8M	$308.9M	$322.2M
YoY Change	-13.69%	-12.48%	-7.37%
TOTAL ASSETS
Total Short-Term Assets	$84.22M	$73.54M	$78.69M
Total Long-Term Assets	$305.8M	$308.9M	$322.2M
Total Assets	$390.0M	$382.4M	$400.9M
YoY Change	2.29%	-0.11%	4.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$233.0K	$375.0K	$2.713M
YoY Change	-51.86%	-17.58%	362.97%
Accrued Expenses			$3.031M
YoY Change			9.78%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$174.2M	-$183.4M	-$185.9M
YoY Change	-13.55%	-7.36%	-6.47%
Common Stock	$117.0K	$117.0K	$117.0K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$380.9M	$371.8M	$367.5M
YoY Change
Total Liabilities & Shareholders Equity	$390.0M	$382.4M	$400.9M
YoY Change	2.29%	-0.11%	4.54%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$9.156M	$2.532M
YoY Change	-354.83%	203.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		$15.14M
YoY Change		-468.9%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$34.00K
YoY Change
NET CHANGE
Cash From Operating Activities		$15.14M
Cash From Investing Activities		$0.00
Cash From Financing Activities		-$34.00K
Net Change In Cash		$15.10M
YoY Change		-468.07%
FREE CASH FLOW
Cash From Operating Activities		$15.14M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6963000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5536000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	4000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	37000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	6998000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5599000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7288000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5011000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	164000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	767000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	161000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1518000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1426000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9573000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6434000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2575000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	835000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2532000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2532000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	835000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	835000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69181047	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70419665	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69309019	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	367547000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	371768000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	348482000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	783000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	835000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	350100000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2532000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	835000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	4000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	37000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1681000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	743000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7288000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5011000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	37000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	21000000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	usd
CY2024Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-96000	usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-1104000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-23053000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2289000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-20187000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-478000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15136000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4103000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	34000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15102000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4103000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55484000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17004000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70586000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12901000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	173000	usd
CY2024Q1	gato	Interest Earned Excluding Capitalized Interest Operating Activities InterestEarnedExcludingCapitalizedInterestOperatingActivities	767000	usd
CY2023Q1	gato	Interest Earned Excluding Capitalized Interest Operating Activities InterestEarnedExcludingCapitalizedInterestOperatingActivities	161000	usd
CY2024Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	696000	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	691000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1379000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1914000	usd
CY2024Q1	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	403000	usd
CY2023Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	20000000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	8000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	37000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2486000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	22642000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	380000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	255000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	375000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2713000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4700000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3031000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1762000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3215000	usd
CY2024Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	3000000	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	24000000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	414000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	387000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	125000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	10376000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	33357000	usd
CY2024Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1403000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1681000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	743000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0386
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5800
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2532000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	2532000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	835000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	835000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69181047	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69162223	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70419665	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69309019	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	31000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	26000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6963000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5536000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	37000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7288000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5011000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	164000	usd
CY2024Q1	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	767000	usd
CY2023Q1	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	161000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1518000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1426000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Assets Assets	382399000	usd
CY2023Q1	us-gaap	Assets Assets	382830000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-020650-index-headers.html	Edgar Link	pending
0001628280-24-020650-index.html	Edgar Link	pending
0001628280-24-020650.txt	Edgar Link	pending
0001628280-24-020650-xbrl.zip	Edgar Link	pending
ceocert10-q2024q1.htm	Edgar Link	pending
cfocert10-q2024q1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gato-20240331.htm	Edgar Link	pending
gato-20240331.xsd	Edgar Link	pending
gato-20240331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
gato-20240331_cal.xml	Edgar Link	unprocessable
gato-20240331_def.xml	Edgar Link	unprocessable
gato-20240331_htm.xml	Edgar Link	completed
gato-20240331_lab.xml	Edgar Link	unprocessable
gato-20240331_pre.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
soxcert10-q2024q1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GATO
Gatos Silver, Inc. Stock $gato

2024 Q2 Form 10-Q Financial Statement

#000162828024020650 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GATO Gatos Silver, Inc. Stock $gato

2024 Q2 Form 10-Q Financial Statement

#000162828024020650 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GATO
Gatos Silver, Inc. Stock $gato